EksoNR is designed by clinicians for clinicians to help patients with weakness or paralysis of the lower extremities regain functional mobility. It supports rehabilitation for individuals affected by stroke, multiple sclerosis (MS), spinal cord injury (SCI), and acquired brain injury (ABI). This broad clearance means that rehab facilities using the EksoNR are able to offer exoskeleton therapy to the widest patient population among all mobile exoskeletons on the market. EksoNR allows therapists to include pre-gait activities as well as advanced gait options which allows therapists to treat patients across the continuum of care; from early mobility to outpatient based programs.

With more than 200 clinical studies and publications, EksoNR is the most researched exoskeleton in the field of neurorehab. Rehabilitation centers benefit not only from its clinical impact but also from significant economic value.

Ekso Bionics supports partners with comprehensive service, training, and ongoing clinical support, ensuring a smooth and successful integration into everyday practice.

EksoNR brings advanced robotic rehabilitation to the Middle East—powerful, evidence-based, and ready to elevate patient outcomes.

If you would like more information on how an EksoNR program can benefit your facility through improved outcomes, enhanced efficiency, increased patient catchment, and cost reduction please visit us at our booth.